Literature DB >> 7632544

Interleukin-1 beta in intravenous albumin preparations.

K Kaneko, Y Suzuki, K Yabuta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7632544     DOI： 10.1007/bf02254231

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  5 in total

1.  Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin.

Authors:  W Borth; T A Luger
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

2.  Ammonium in intravenous albumin preparations.

Authors:  R A Chamuleau; G G Jörning; F G Korse; P J Roos
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

3.  Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations.

Authors:  R Blasczyk; U Westhoff; H Grosse-Wilde
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

4.  Aggravation of minimal change nephrotic syndrome by administration of human albumin.

Authors:  A Yoshimura; T Ideura; S Iwasaki; T Taira; S Koshikawa
Journal:  Clin Nephrol       Date:  1992-03       Impact factor: 0.975

5.  Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.

Authors:  H Y Lan; D J Nikolic-Paterson; M Zarama; J L Vannice; R C Atkins
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.